Innate Pharma Highlights FDA-Approved Lumoxiti® at ASH 2019
December 08, 2019 09:00 ET
|
INNATE PHARMA
MARSEILLE, France, Dec. 08, 2019 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) shared new, long-term data from the pivotal...
RAPT Therapeutics and Hanmi Pharmaceutical Announce Collaboration to Develop and Commercialize FLX475 in Asia
December 03, 2019 16:05 ET
|
RAPT Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif. and SEOUL, South Korea, Dec. 03, 2019 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on...
Incysus Therapeutics to Participate in Evercore ISI HealthCONx Conference
November 26, 2019 07:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Fluidigm to Participate in the 31st Annual Piper Jaffray Healthcare Conference
November 13, 2019 16:05 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Incysus Therapeutics to Present at the New York Oncology Investor Conference
November 07, 2019 07:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Immunicum AB (publ) Delårsrapport Januari – september 2019
November 06, 2019 02:00 ET
|
Immunicum AB
Pressmeddelande 6 november 2019 Immunicum AB (publ) Delårsrapport Januari – september 2019 Topline-resultaten för MERECA-studien - en viktig milstolpe för Immunicum JULI – SEPT I...
Immunicum AB (publ) Interim Report January – September 2019
November 06, 2019 02:00 ET
|
Immunicum AB
Press Release 6 November 2019 Immunicum AB (publ) Interim Report January – September 2019 Important milestone passed with MERECA topline results SIGNIFICANT EVENTS DURING JULY - SEPTEMBER ...
Fluidigm Announces Third Quarter 2019 Financial Results
November 05, 2019 16:05 ET
|
Fluidigm Corporation
Third quarter revenue decreased 8.5 percent to $26.5 million; year-to-date revenue increased 5 percent to $84.8 million Third quarter consumables revenue increased 11 percent Year-to-date mass...
Cytek Biosciences Expands Global Reach
October 30, 2019 10:05 ET
|
Cytek Biosciences
FREMONT, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Cytek Biosciences Inc.'s mission to make full spectrum flow cytometry accessible to a larger number of scientists continues to resonate with the...
Provectus Announces Acceptance of PV-10® Poster Presentations at ESMO Immuno-Oncology Congress 2019
October 24, 2019 07:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from an ongoing clinical trial of lysosomal-targeting, cancer immunotherapy PV-10 (rose bengal...